ANRO
ANRO
NYSE · Pharmaceuticals

Alto Neuroscience Inc

$21.87
-1.43 (-6.14%)
As of Nov 7, 2:03 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +1.4% upside
Low Target $14.63
Average Target $22.17
High Target $27.87
Current Price $21.87
Current
$21.87
Target
$22.17
$14.63 $22.17 avg $27.87
Scenario Analysis
Bear Case
$14.63
-33.1%
Low target
Base Case
$22.17
+1.4%
Avg target
Bull Case
$27.87
+27.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$37.48
-41.6% from high
52-Week Low
$10.62
+105.9% from low
Target vs 52W High
$22.17
-40.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%